MODEL REPLY
1. Pharmaceutical Treatment
For patients with Type 1 Diabetes (T1D), insulin therapy is covered by the General Healthcare System (GeSY). For patients with Type 2 Diabetes (T2D), GeSY covers the cost of antidiabetic medications included in the therapeutic protocols, including newer treatments, provided that specific criteria and approvals are met.
For each medication dispensed through GeSY, the patient usually pays a co-payment of €1.
If the patient or physician chooses a product that is more expensive than the one fully reimbursed by GeSY, the patient pays the so-called “Contribution II”, which is the price difference between the reimbursed medication and the more expensive alternative.
2. Blood Glucose Monitoring Systems
Glucose meters and test strips are provided free of charge, provided there is a prescription from a physician contracted with GeSY and they are obtained from a participating pharmacy.
The maximum number of test strips available per month is:
• Up to 125 test strips per month for insulin-dependent patients (T1D).
• Up to 50 test strips per month for non-insulin-dependent patients (T2D).
3. Continuous Glucose Monitoring Systems (CGM)
At present, GeSY widely provides the FreeStyle Libre 2 continuous glucose monitoring system by Abbott free of charge. This consists of a sensor worn on the upper arm that provides continuous glucose readings. However, there are concerns that a patient cost-sharing mechanism may be introduced in the future.
For patients with Type 1 Diabetes:
• Continuous Glucose Monitoring (CGM) / Flash Glucose Monitoring sensors, mainly FreeStyle Libre, are provided.
• In certain cases, these may be combined with an insulin pump following approval by a specialist diabetologist.
For patients with Type 2 Diabetes:
• Blood glucose meters and testing supplies are provided.
• Continuous glucose monitoring sensors may be approved for patients receiving insulin therapy or meeting specific clinical criteria documented by their treating physician.
According to an announcement by the Health Insurance Organization (HIO) dated 15 January 2024, the age restriction for the provision of continuous glucose monitoring systems has been abolished.
The medical criterion for eligibility is that the individual must be receiving insulin treatment, including women with gestational diabetes.
It is the responsibility of the treating physician to determine whether the patient, or, where applicable, their parents or guardians can follow instructions and make appropriate use of the system.
4. Insulin Pumps and Advanced Systems
Insulin pumps are provided free of charge primarily to patients with Type 1 Diabetes, particularly children, adolescents, and individuals at increased risk of hypoglycemia.
The provision of insulin pumps requires medical assessment and recommendation by a specialist physician.
Since 2023, there has been no age restriction for receiving insulin pumps (previously eligibility was limited to patients under 25 years of age).
However, regular reassessment is required, usually every year, for continued eligibility.
At present, only tubed insulin pumps are provided free of charge, although the Health Insurance Organization plans to introduce additional pump models. The process has been delayed due to legal appeals and procurement challenges.
5. Other Medical Equipment and Supplies
Insulin Administration Equipment
• Insulin pens.
• Needles for insulin pens.
• Insulin syringes, where required.
• Insulin vials or cartridges prescribed through the GeSY medication system.
Supplies for Insulin Pumps
For approved insulin pump users the following may be provided:
• Infusion sets.
• Reservoirs.
• Connection tubing.
• Adhesive fixation products and insertion accessories.
• Transmitters and sensors when the pump is integrated with a CGM system.
Hypoglycemia Management Equipment
Patients at increased risk of severe hypoglycemia may be prescribed:
• Glucagon preparations for the emergency treatment of severe hypoglycemia. Coverage is provided through the pharmaceutical benefits system when medically indicated.
• Low-glucose alert systems through CGM devices.
Advanced Diabetes Technologies
For selected patients, particularly those with Type 1 Diabetes:
• Continuous Subcutaneous Insulin Infusion (CSII) pumps.
• Patch pumps (tubeless insulin pumps).
• Integrated sensor-pump systems with automated basal insulin adjustment (Hybrid Closed Loop systems or “artificial pancreas” technology).
6. Financial and Social Benefits
A person with diabetes in Cyprus does not receive a general monthly or annual allowance solely because of the condition itself.
However, a diabetic may be eligible for benefits if he/she:
• Has developed serious complications resulting in disability.
• Has experienced a substantial reduction in work capacity.
• Has permanent functional impairment (e.g. severe vision loss, amputation, kidney failure or severe mobility disability).
Benefits may be provided, depending on the circumstances, either through the Social Insurance Services, provided disability and contribution criteria are met, or through the Deputy Ministry of Social Welfare.
There are no automatic tax deductions specifically granted to diabetics. However, general tax deductions may apply depending on income level, insurance arrangements, and any officially recognized disability.
7. Access to Healthcare Services
Depending on individual needs, people with diabetes may have access to:
• Follow-up care through diabetes clinics in public or private hospitals contracted with GeSY.
• Dietetic and nutrition services through GeSY.
• HbA1c testing and other laboratory monitoring tests.
• Ophthalmological screening and diabetic retinopathy services.
• Nephrology, cardiology, and podiatry monitoring when required.
In addition, the State Health Services Organization (OKYPY) operates diabetes centers and provides education and counseling services for diabetes self-management.
Educational programs may include:
• Blood glucose monitoring and tracking.
• Proper use of insulin and other diabetes therapies.
• Aknowledgement and management of hypoglycemia.
• Nutrition, physical activity, and healthy lifestyle habits.
• Prevention and early detection of complications, including foot-related problems.
Support Services Provided by the Cyprus Diabetic Association
The Cyprus Diabetic Association traditionally provides:
• Patient education and information.
• Psychosocial support.
• Information on rights and available government benefits.
• Advocacy for access to new diabetes technologies.
• Camps and programs for children with diabetes.
These services are supportive in nature and do not replace the healthcare services and benefits provided through GeSY or the Ministry of Health.